secwatch / observer

8-K filed May 8, 2025, 7:59 PM ET ticker MNKD CIK 0000899460

earnings confidence high sentiment positive materiality 0.75

MannKind Q1 revenue $78M (+18% YoY); net income $13.2M (+24%)

MANNKIND CORP

2025-Q1 EPS reported $0.04 revenue$78,354,000

1Q25 revenue $78.4M (+18% YoY); GAAP net income $13.2M (+24%); non-GAAP net income $21.6M (+43%).
Royalty revenue $30M (+32%) from increased Tyvaso DPI demand; collaborations & services $29.4M (+18%) from United Therapeutics.
Afrezza NRx grew 20% YoY; sBLA for pediatric approval expected mid-2025.
MNKD-101 Phase 3 ICON-1: 55 patients randomized, 85% sites activated; target 100 patients by YE 2025.
Cash & investments $198M; MNKD-201 (nintedanib DPI) expected to advance to next phase in 2H 2025.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000950170-25-066426
form_type: 8-K
ticker: MNKD
cik: 0000899460
company_name: MANNKIND CORP
filed_at: 2025-05-08T23:59:59+00:00
discovered_at: 2026-05-14T18:02:51.738927+00:00
generated_at: 2026-05-22T06:23:21.164505+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000950170-25-066426
json_url: https://secwatch.observer/filing/0000950170-25-066426.json
markdown_url: https://secwatch.observer/filing/0000950170-25-066426.md
text_url: https://secwatch.observer/filing/0000950170-25-066426.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/899460/000095017025066426/0000950170-25-066426-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/899460/000095017025066426/mnkd-20250508.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

YSWY

Yesway reports Q1 net income $30.2M, Adjusted EBITDA $59.2M; introduces FY2026 outlook

Yesway, Inc. June 2, 2026, 7:35 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

VSCO

Victoria's Secret Q1 sales up 15% to $1.56B, beats guidance; raises FY2026 outlook

Victoria's Secret & Co. June 2, 2026, 7:01 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

CTRN

Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M

Citi Trends Inc June 2, 2026, 6:58 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SIG

Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance

SIGNET JEWELERS LTD June 2, 2026, 6:54 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Dollar General Q1 EPS $2.00 beats expectations; raises FY2026 EPS guidance

DOLLAR GENERAL CORP June 2, 2026, 6:54 AM ET earnings Items 2.02, 5.07, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HIVE

HIVE FY2026 revenue $297.8M (+158% YoY); GAAP net loss $148.4M

HIVE Digital Technologies Ltd. June 2, 2026, 6:23 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DCI

Donaldson Q3 FY2026 sales $995.1M (+5.8%), adj. EPS $1.06 (+7.1%)

DONALDSON Co INC June 1, 2026, 5:41 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

GMRS

GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B

GMR Solutions Inc. June 1, 2026, 4:45 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000950170-25-066426

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.